Teva Pharmaceuticals’ Patent Dispute

Borenius advised Teva Pharmaceuticals on the case. Teva Pharmaceuticals partecipated in a patent dispute before the Finnish Market Court concerning Bristol-Myers Squibb Holdings Ireland Unlimited Company’s...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Teva Pharmaceutical’s Bonds Offering

Baker McKenzie advised the syndicate of 10 underwriters on the deal. Teva Pharmaceutical Industries Limited executed a multi-tranche USD 2.5 billion (equivalent) (upsized from USD 2.06 billion)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Teva v. Novartis

Pinsent Masons represented Teva in the dispute, while Bristows represented Novartis. Teva brought revocation proceedings against two Novartis patents concerning deferasirox, EP 29 64 202 and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

MODAG’s Collaboration Agreement with Teva

Baker McKenzie advised Modag GmbH on the deal. Blomstein advised Teva Pharmaceutical Industries Limited. MODAG GmbH signed a collaboration agreement with Teva Pharmaceutical Industries Ltd. on the exclusive...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here